Archimedes Capital invests in a range of venture capital and private equity deals, from seed to pre-IPO or later, focusing on those opportunities that utilize or can be accelerated to success with what the firm calls 'global advantage.'Archimedes' principals have been building and advising companies for nearly three decades using the global advantage approach. The firm's partners have invested over $350 million since 1993. Founder, Matt Ocko, has been a Partner of VantagePoint Venture Partners and General Partner of Softbank Technology Ventures (of which he was a founder). He is also a venture partner at Sevin Rosen Funds (see profile).